Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- BIOELECTRON TECH CORP
- Publication Date
- 2015-02-26
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority benefit of U.S. provisional patent application No. 61 / 505,051, filed Jul. 6, 2011. The entire contents of that application are incorporated by reference herein.TECHNICAL FIELD OF THE INVENTION
[0002] The present invention relates to a method of treating methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones (including tocotrienol hydroquinones), for example, alpha-tocotrienol quinone.BACKGROUND OF THE INVENTION
[0003] Organic acidurias (also known as organic acidemias) are a set of disorders caused by defects in amino acid metabolism, resulting in an abnormal accumulation of acids in the body. See Rezvani I., “Defects in metabolism of amino acids,” in: Kliegman R M, Behrman R E, Jenson H B, Stanton B F, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa.: Saunders Elsevier; 2007, Chap 85.
[0004] Methylmalonic aciduria (methylmalonic acidemia, MMA) is caused ...